title: Adalimumab treatment in intestinal Behçet's disease: Relationship with ectopic mucin 5AC glycoprotein expression and endoscopic improvement.
authors.affiliation: Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Electronic address: tmizoshi@med.nagoya-cu.ac.jp.
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Mizoshita
authors.affiliation: Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
authors.forename: Satoshi
authors.initials: S
authors.lastname: Tanida
authors.affiliation: Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
authors.forename: Takashi
authors.initials: T
authors.lastname: Joh
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy*; D002432:Cecum / Q000378:metabolism; D016145:Endoscopy, Digestive System; D006801:Humans; D007082:Ileum / Q000378:metabolism; D007150:Immunohistochemistry; D007410:Intestinal Diseases / Q000188:drug therapy* / Q000378:metabolism; D055271:Mucin 5AC / Q000378:metabolism; D016896:Treatment Outcome; D014456:Ulcer / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D018501:Antirheumatic Agents; D055271:Mucin 5AC; D000068879:Adalimumab